Abstract
Despite extensive structural work, little is known about how MPER-specific HIV antibodies develop. Krebs et al. describe the initiation and early development of three MPER-directed HIV broadly neutralizing antibody lineages from a single donor of the RV217 cohort. One of the antibody lineages appears particularly promising for vaccine design, as it achieved high neutralizing breadth with low mutation from germline.
Original language | English |
---|---|
Pages (from-to) | 677-691.e13 |
Journal | Immunity |
Volume | 50 |
Issue number | 3 |
DOIs | |
State | Published - 19 Mar 2019 |
Externally published | Yes |
Keywords
- HIV envelope
- neutralizing antibody
- next-generation sequencing